<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03823092</url>
  </required_header>
  <id_info>
    <org_study_id>17/WA/0180</org_study_id>
    <nct_id>NCT03823092</nct_id>
  </id_info>
  <brief_title>Polarization Perception in Health and Disease. Testing a New Sight Test</brief_title>
  <acronym>TaNSiT</acronym>
  <official_title>Polarization Perception in Health and Disease. Testing a New Sight Test: The TaNSiT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Warwickshire NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>South Warwickshire NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to assess the utility of human polarization pattern perception for the detection,&#xD;
      diagnosis and monitoring of eye disease&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The recently described high sensitivity of the human eye to differentiate small angular&#xD;
      differences in linear polarization and evidence supporting its macular origin (Misson,&#xD;
      Anderson; 2017) suggests that human polarization sensitivity might be a useful diagnostic&#xD;
      tool for macular disease. This augments a previous study in which we demonstrated the ability&#xD;
      of the human visual system to detect isochromatic isoluminant polarization modulated pattern&#xD;
      stimuli (Misson et al 2015).&#xD;
&#xD;
      This is an exploratory 'proof-of-concept' study to determine the clinical value of&#xD;
      polarization pattern perception, PPP, in health and disease. We further propose that PPP&#xD;
      might be valuable for the diagnosis, monitoring and early detection of macular disease. The&#xD;
      latter includes common blinding conditions such as age related macular degeneration and&#xD;
      diabetic retinopathy. It is also intended to investigate the effect of cataracts and cataract&#xD;
      surgery on PPP: cataract surgery modifies the optics of the eye so might also modify PPP.&#xD;
&#xD;
      PPP is measured using a modification of the methodology described in (Misson et al 2015) and&#xD;
      (Misson, Anderson; 2017) whereby polarization modulated patterns are presented on a modified&#xD;
      LCD display. The observer's task is to report if they see an image and to describe the image.&#xD;
      Images comprise simple patterns or traditional optotypes. A standard set of images are&#xD;
      presented in pseudorandom order and the response recorded. A total score, the polarization&#xD;
      pattern perception score PPP is then determined from the number of images seen/identified. A&#xD;
      more refined metric, the polarization visual acuity pVA, will be derived from the response to&#xD;
      the optotype stimuli. These data are then compared to conventional tests of visual structure&#xD;
      and function including logMAR visual acuity, ocular examination and OCT scan data.&#xD;
&#xD;
      The study in anticipated to comprise:&#xD;
&#xD;
      Phase 1. Normative Evaluation: observational prospective cross-sectional.. A preliminary&#xD;
      normative study will be undertaken on staff members. The aim is to quantify normative values&#xD;
      in preparation for the clinical studies.&#xD;
&#xD;
      Hypotheses to be tested:&#xD;
&#xD;
        1. that healthy subjects can perceive polarization stimuli&#xD;
&#xD;
        2. that there is a threshold of polarization image resolution (pVA) analogous to visual&#xD;
           acuity. Normative PPP and pVA data will be collected.&#xD;
&#xD;
      Phase 2 Patient Group: observational Prospective cross-sectional / case-control.&#xD;
&#xD;
      Phase 2 subjects will comprise normals and patients with cataracts/pseudophakia and/or AMD,&#xD;
      other macular pathology, diabetic retinopathy..&#xD;
&#xD;
      The aim of this phase is to determine the effect, if any, of particular eye conditions on&#xD;
      pVA/PPP alone and in comparison with other test parameters.&#xD;
&#xD;
      Hypotheses to be tested:&#xD;
&#xD;
        1. that eye conditions affect pVA/PPP&#xD;
&#xD;
        2. that specific eye conditions have a selective effect on pVA/PPP&#xD;
&#xD;
        3. that pseudophakia affects pVA/PPP&#xD;
&#xD;
      Phase 3: Cataract pre-op v post op pVA/PPP: prospective interventional case-control.&#xD;
&#xD;
      Timescale:concurrent with Phase 2 A subset of the phase 2 cataract patients will undergo&#xD;
      cataract surgery according to clinical need. These patients are routinely reviewed 4 - 8&#xD;
      weeks post-op when the opportunity will arise to repeat pVA/PPP measurement. The fellow eye&#xD;
      will serve as a control / provide data for repeatability assessment.&#xD;
&#xD;
      The aims of this phase are&#xD;
&#xD;
        1. to determine the repeatability of pVA/PPP testing in a heterogeneous patient group&#xD;
&#xD;
        2. to determine the effect of cataract surgery on the pre-operative pVA/PPP results&#xD;
&#xD;
        3. to determine if pVA/PPP is a useful determinant of post-operative visual outcome.&#xD;
&#xD;
      Hypotheses:&#xD;
&#xD;
        1. that pVA/PPP testing is repeatable&#xD;
&#xD;
        2. that there is a difference in pVA/PPP pre and post cataract surgery&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 9, 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>polarization sensitivity</measure>
    <time_frame>18 month</time_frame>
    <description>determine and compare polarization sensitivity between groups</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cataract</condition>
  <condition>Age Related Macular Degeneration</condition>
  <condition>Pseudophakia</condition>
  <condition>Macular Disease</condition>
  <condition>Diabetic Retinopathy</condition>
  <condition>Retinal Disease</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>phakic participants with no evidence of eye disorders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cataract</arm_group_label>
    <description>participants with cataract</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AMD</arm_group_label>
    <description>participants with age related macular degeneration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pseudophakic</arm_group_label>
    <description>particpiants who have had cataract surgery with intraocular lens implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>other macula</arm_group_label>
    <description>participants with macular ddisorders other than AMD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DR</arm_group_label>
    <description>participants with diabetic retinopathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>polarization sensitivity</intervention_name>
    <description>test of polarization vision as described in Study Description</description>
    <arm_group_label>AMD</arm_group_label>
    <arm_group_label>Cataract</arm_group_label>
    <arm_group_label>DR</arm_group_label>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Pseudophakic</arm_group_label>
    <arm_group_label>other macula</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients and staff of the Eye Department of South Warwickshire NHS Trust&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - willing and able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unwilling or unable to provide informed consent&#xD;
&#xD;
          -  individuals wishing to exit the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gary P Misson, PhD FRCOphth</last_name>
    <phone>+44 01926495321</phone>
    <email>gary.misson@swft.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jo Williams</last_name>
    <phone>+44 01926495321</phone>
    <email>jo.williams@swft.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>South Warwickshire NHS Foundation Trust</name>
      <address>
        <city>Warwick</city>
        <state>Warwickshire</state>
        <zip>CV37 0PZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary P Misson, PhD FRCOphth</last_name>
      <phone>+44 01926495321</phone>
      <email>gary.misson@swft.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Jo Williams</last_name>
      <phone>+44 01926495321</phone>
      <email>jo.williams@swft.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen J Anderson, PhD FRCOptom</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Misson GP, Timmerman BH, Bryanston-Cross PJ. Human perception of visual stimuli modulated by direction of linear polarization. Vision Res. 2015 Oct;115(Pt A):48-57. doi: 10.1016/j.visres.2015.08.004. Epub 2015 Aug 28.</citation>
    <PMID>26291073</PMID>
  </results_reference>
  <results_reference>
    <citation>Misson GP, Anderson SJ. The spectral, spatial and contrast sensitivity of human polarization pattern perception. Sci Rep. 2017 Nov 29;7(1):16571. doi: 10.1038/s41598-017-16873-6.</citation>
    <PMID>29185499</PMID>
  </results_reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 28, 2019</study_first_submitted>
  <study_first_submitted_qc>January 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2019</study_first_posted>
  <last_update_submitted>January 28, 2019</last_update_submitted>
  <last_update_submitted_qc>January 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Warwickshire NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Gary Misson</investigator_full_name>
    <investigator_title>Consultant ophthalmologist</investigator_title>
  </responsible_party>
  <keyword>macular function</keyword>
  <keyword>polarization perception</keyword>
  <keyword>Haidinger's brush</keyword>
  <keyword>vision testing</keyword>
  <keyword>cataract</keyword>
  <keyword>age related macular degeneration</keyword>
  <keyword>pseudophakia</keyword>
  <keyword>macular disease</keyword>
  <keyword>retinal disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
    <mesh_term>Pseudophakia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

